1. ������Ƥ����������
2.
3. ������Ƥ����������Ƥ����

Ŀ�� ̽�ֹ�������÷������������Ƚ�δ����������÷�����ߺ�Ѫ��̶�������÷������÷���Ļ����ʡ����� �Ժ�����о��ķ������Գ������Ϊ����÷�����ߣ�δ���ƻ����ƺ����Ѫ��̶�����ȡ�Լ�Һ�������Բ��о�ʵ�������飬ɸ����÷�����ߡ���� δ����������÷����������21.98%��60/273��Ϊ��÷��������10.99%��30/273��Ϊ��֢״��÷����10.99%��30/273��Ϊ��֢״��÷��������÷������Ѫ��̶�����÷������83����1.20%��1/83��������÷����ϣ�Ϊ��֢״��÷����������δ����������÷�����У�����÷����������������÷���������������ͳ��ѧ���壬ǰ��������ں��ߡ����� �ڿ�÷�����ƺ����÷��Ѫ��̶�������÷�������Ŀ��������δ�����Ƶ�����÷��С����÷������Ҫ������δ�����Ƶ�DZ��÷����Ⱥ�У���ʾδ�����Ƶ�����÷������÷����������ҪΣ�����ء�

Objective To compare the incidence of neurosyphilis in untreated patients with latent syphilis ��LS�� versus serafast patients treated for LS in Guangzhou City. Methods A cross=sectional study was performed. Cerebrospinal fluid was obtained from 356 patients who were first diagnosed with LS, and venereal disease research laboratory ��VDRL�� test was conducted to screen neurosyphilis. Results Among 273 untreated patients with LS, 60��21.98%�� were diagnosed with neurosyphilis, and of the 60 patients, 30 with asymptomatic , and the other 30 were symptomatic. In 83 serafast patients treated for LS, only 1 ��1.2%�� was diagnosed with neurosyphilis, while no symptom was observed in this patient. In untreated cases of LS, the mean age was significantly lower in patients without neurosyphilis than in those with neurosyphilis. Conclusions Patients with untreated LS are more likely to develop neurosyphilis compared with serafast patients treated for LS, and neurosyphilis mainly occurs in untreated patients with LS, suggesting that untreated latent syphilis is an important risk factor for the development of neurosyphilis.

null

1. Singh, AE, Romanowski, B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev, 1999, 12(2): 187-209. 2. Golden, MR, Marra, CM, et al. Update on syphilis: resurgence of an old problem. JAMA, 2003, 290(11): 1510-1514. 3. Marra, CM. Neurosyphilis. Curr Neurol Neurosci Rep, 2004, 4(6): 435-40. 4. ��ǧ��, �Ź���. �Դ��������ٴ�����ָ��. �Ϻ����Ϻ���ѧ���������磬2007. 5��4-5. 5. ��Ծƽ. �Դ�������ʵ�������ָ��. �Ϻ����Ϻ���ѧ���������磬2007.12��4-18 6. Wile, UJ, Stokes, JH. Involvement of the nervous system during the primary stage of syphilis. JAMA, 1915, 64(12): 979–982. 7. Chesney, AM, Kemp, JE. Incidence of Spirochaeta pallida in cerebrospinal fluid during early stage of syphilis. JAMA 1924, 83(22):1725–1728. 8. Lukehart SA, Hook EW, et al. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med, 1988, 109(11): 855-862 9. Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines - 2006. MMWR, 2006, 55(No. RR-11).